Showing results (181-190 of 259) with videos related to

Sort By:
Pageof 26
Microbiome|May 30, 2020
Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteriaXingxing Jian, Yinghong Zhu, Jian Ouyang, et al.
Nature Communications|April 13, 2023
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple MyelomaChunmei Kuang, Meijuan Xia, Gang An, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2024
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell SequencingJian Cui, Xiaoyun Li, Shuhui Deng, et al.
Ebiomedicine|April 19, 2020
Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimabYuankai Shi, Hang Su, Yongping Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2024
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)Huishou Fan, Bing Wang, Lihui Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 6, 2026
Polatuzumab Vedotin Plus Rituximab, Gemcitabine, and Oxaliplatin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Results From the Phase III, Randomized POLARGO TrialMatthew Matasar, Zhiming Li, Theodoros P Vassilakopoulos, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2022
Genetic Aberrations and Interaction of NEK2 and TP53 Accelerate Aggressiveness of Multiple MyelomaXiangling Feng, Jiaojiao Guo, Gang An, et al.
Current Research in Translational Medicine|July 5, 2020
CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challengesYongxian Hu, Elaine Tan Su Yin, Yingying Yang, et al.
Annals of the Academy of Medicine, Singapore|April 1, 2026
The APLC expert consensus recommendations on the management of chronic lymphocytic leukaemia in AsiaShin Yeu Ong, Thomas Chan, Eric Wai Choi Tse, et al.
Scientific Reports|July 17, 2020
Pharmacokinetics and safety of IBI301 versus rituximab in patients with CD20+ B-cell lymphoma: a multicenter, randomized, double-blind, parallel-controlled studyBo Jiang, Xiaoyan Ke, Qingyuan Zhang, et al.
Pageof 26